Preliminary research indicate conolidine may possibly inhibit precise ion channels, lowering neuronal excitability and restricting soreness signals. This mechanism is particularly applicable in neuropathic soreness, wherever abnormal signaling will cause persistent discomfort. On top of that, conolidine appears to impact G protein-coupled receptor